Control Bionics Raises $310,000 Through Shortfall Shares

Control Bionics Ltd. (AU:CBL) has released an update.

Control Bionics Ltd has successfully raised $310,000 through the issuance of shortfall shares from its Non-Renounceable Rights Issue, resulting in 4.428 million shares and 2.214 million options. The placement was facilitated by Lynx Advisors, which received 650,000 options for arranging the transaction. This strategic move underscores Control Bionics’ commitment to advancing its innovative medical devices.

For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.